CLOs on the Move

GNYHA Ventures

www.gnyhaventures.com

 
GNYHA Ventures is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 250-1000
  • Annual Revenue: $500M-1 Billion

Executives

Name Title Contact Details

Similar Companies

BioMedical Strategies

BioMedical Strategies is a La Jolla, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Simavita

Simavita is a medical device company operating in the digital healthcare sector that has developed an innovative world first solution for the management of urinary incontinence, with a focus on the elderly. Our flagship product is the SIM™ platform technology, an instrumented Incontinence assessment application that provides evidence based Incontinence management care plans to the residential aged care market.   Simavita is committed to continuously innovating and expanding its core SIM™ platform technology to improve the level of Incontinence care, create efficiencies, promote effective utilisation of our society`s finite resources and enhance the dignity of care for our ageing population.

comedIT Group

comedIT Group is a Atlantic Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

American Medical Instruments

American Medical Instruments, Inc. is a North Dartmouth, MA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

iSpecimen

Headquartered in Lexington, MA, iSpecimen offers an online marketplace for the purchase of human biospecimens, providing researchers with the specimens they need from the patients they want. The iSpecimen Marketplace connects healthcare organizations that have access to patients and specimens with the scientists who need them for their research and development projects. Proprietary, cloud-based technology enables researchers to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. Researchers easily and compliantly gain access to specimens to drive scientific discovery. Partner sites gain an opportunity to contribute to biomedical discovery as well as their bottom line. And ultimately, healthcare advances for all.